MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1517/14656566.2013.800045

Медицинская библиотека · Expert opinion on pharmacotherapy · 2013

Treating myoclonic epilepsy in children: state-of-the-art.

Striano Pasquale, Belcastro Vincenzo

СтатьяОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

Myoclonic seizures can be observed in various clinical settings and different epileptic conditions, including some forms of both diopathic and symptomatic epilepsies. Relatively little has been written on treatment of myoclonic seizures. Some old antiepileptic drugs, such as valproate and some benzodiazepines, are widely used but more treatment options exist today for some newer antiepileptic drugs. Nevertheless, patients can be refractory to drug treatment and some drugs may exacerbate or even induce myoclonus.

AREAS COVERED: Key safety, tolerability, and efficacy data are presented for different antiepileptic drugs with antimyoclonic effect, alone and/or in combination.

EXPERT OPINION: Treatment of myoclonic seizures in children is mainly based on prospective and retrospective studies, with little evidence from randomized clinical trials. Valproate is commonly the first choice alone or in combination with some benzodiazepines or levetiracetam. There is still insufficient evidence for the use of topiramate and zonisamide as monotherapy. Of major importance remains avoidance of medication that may aggravate the seizures. Better understanding of pathophysiologic mechanisms of myoclonic seizures and myoclonic epilepsies could yield great improvement in the treatment and quality of life of patients.

Для цитирования: Striano Pasquale, Belcastro Vincenzo. Treating myoclonic epilepsy in children: state-of-the-art.. Expert opinion on pharmacotherapy. 2013. DOI: 10.1517/14656566.2013.800045.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.